MaxCyte Stock

MaxCyte Inventory

The Inventory of MaxCyte (MXCT) as of Sep 5, 2026 is 8.91 M USD. In the previous year, Inventory was 12.23 M USD — a change of -27.11% (lower).

Inventory

8.91 MUSD

YoY

-27.11%

Last updated:

Inventory of MaxCyte is 2026 8.91 M USD. Inventory of MaxCyte was 2025 12.23 M USD. It decreases by -27.11% lower compared to the previous year.

The MaxCyte Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2017
1.30 M USD
Jan 1, 2018
2.20 M USD
Jan 1, 2019
3.70 M USD
Jan 1, 2020
4.30 M USD
Jan 1, 2021
5.20 M USD
Jan 1, 2022
8.60 M USD
Jan 1, 2023
12.23 M USD
Jan 1, 2024
8.91 M USD
The MaxCyte Inventory history
YEARInventoryYoY
8.91 MUSD-27.11%
12.23 MUSD+42.20%
8.60 MUSD+65.38%
5.20 MUSD+20.93%
4.30 MUSD+16.22%
3.70 MUSD+68.18%
2.20 MUSD+69.23%
1.30 MUSD0.00%
1.30 MUSD+18.18%
1.10 MUSD+22.22%
900,000.00USD—
Access this data via the Eulerpool API
Get Free API Key

MaxCyte Stock analysis

What does MaxCyte do? MaxCyte Inc is a US biotechnology company specializing in the development of platform-based technologies for the next generation of gene and cell therapies. They offer integrated platform technology for drug manufacturing, research, and development. Their proprietary platform technology, Flow ElectroporationTM, allows for efficient transduction of a variety of cells, making it a valuable tool for the production of CAR-T cell therapies. They also offer services for lentiviral production and customized gene therapy production. MaxCyte has secured $50 million in funding for expansion and has formed important partnerships in the industry. They are a leading player in the development of innovative technologies for gene and cell therapy products. MaxCyte is one of the most popular companies on Eulerpool.

Frequently Asked Questions about MaxCyte stock

Inventory of MaxCyte is 8.91 M USD in 2026.

Inventory of MaxCyte changed from 12.23 M USD to 8.91 M USD, representing a -27.11% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Inventory MaxCyte since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's MaxCyte historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — MaxCyte

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — MaxCyte